Tracking H5 and H7 Avian Influenza in Europe: Clades and Surveillance Trends
- Maguis Gibert
- Jul 26
- 10 min read
Avian influenza no longer fits the old seasonal pattern in Europe. The risk once rose sharply with autumn migration, eased after winter, and left poultry farms a clearer window to recover. Recent H5 viruses have changed that rhythm. Detections in wild birds, outbreaks in poultry, and spillover events in mammals now require attention across much more of the year.
The most important shift is not just that more birds are affected. It is that H5 and H7 avian influenza viruses keep changing through clades, reassortment, and movement across species and regions. Surveillance has to follow that change in near real time.
This article explains how H5 and H7 viruses are tracked in Europe, why clades matter, and what current surveillance trends reveal about risk.

Why H5 and H7 receive special attention
Avian influenza A viruses are classified by two surface proteins, haemagglutinin and neuraminidase. The familiar names, such as H5N1 or H7N7, come from those proteins.
Many avian influenza viruses cause mild or unnoticed infection in wild birds. The problem is that some H5 and H7 viruses can become highly pathogenic avian influenza, often shortened to HPAI, after they adapt in poultry. HPAI can spread quickly through poultry holdings and cause high mortality in chickens, turkeys, ducks, and other kept birds.
That is why H5 and H7 are treated differently from most other subtypes. Even when an H5 or H7 virus is low pathogenic at detection, it can carry a higher regulatory and surveillance priority because of its potential to change.
In Europe, surveillance focuses on three overlapping goals:
Detect HPAI early in wild birds and poultry.
Identify low pathogenic H5 and H7 viruses before they adapt.
Track genetic changes that may affect spread, host range, control measures, or zoonotic risk.
The public health risk from avian influenza in Europe remains mainly linked to occupational or close exposure, such as handling infected birds without protection. Still, animal health and public health systems need to work together because the virus is shared across wildlife, farming, trade, and human interfaces.
This article is informational only and does not replace veterinary, public health, or regulatory guidance.
Clades explain how the virus is related, not just what it is called
A subtype name gives only part of the picture. Two viruses may both be called H5N1, yet belong to different genetic branches and behave differently in the field. That is where clades matter.
A clade is a group of viruses that share a common genetic ancestor. Clade naming helps laboratories, veterinary authorities, and epidemiologists understand how viruses are related and how they are moving.
For H5 viruses, Europe’s recent experience has been shaped strongly by the goose/Guangdong lineage of H5 HPAI viruses. Within that lineage, clade 2.3.4.4b has played a major role in recent European outbreaks. It has been associated with widespread detections in wild birds and repeated incursions into poultry.
The clade label does not replace field investigation. It supports it. When a sequence from a poultry outbreak closely matches viruses found in local wild birds, that suggests one type of pathway. When sequences differ more clearly, investigators may look at other routes, such as animal movements, contaminated equipment, or links between holdings.
Clade analysis helps answer practical questions:
Are current cases part of one regional spread event or several separate introductions?
Are poultry outbreaks linked to local wild bird pressure?
Is a virus moving along migratory flyways?
Has reassortment produced a new genotype that needs closer attention?
Do genetic markers suggest a change in host adaptation?
The answer is rarely simple. Avian influenza viruses have segmented genomes. When two different viruses infect the same host, they can exchange gene segments. This process, called reassortment, can create new genotypes within a known subtype or clade.
That means surveillance cannot stop at subtype detection. Sequencing matters because it shows how the virus is changing underneath the label.
H5 viruses now drive much of the European risk picture
H5 HPAI has become the dominant concern in Europe in recent years. The subtype H5N1 has received the most attention, especially when linked to clade 2.3.4.4b. Other H5 neuraminidase combinations have also appeared at times, including H5N8 and related forms, depending on reassortment and movement patterns.
The pattern is shaped by wild waterbirds, seabirds, poultry density, biosecurity, and season. Ducks, geese, gulls, and some seabird species can all play roles in movement or amplification, although susceptibility and mortality vary by species.
Recent H5 activity has also shown that wild bird surveillance cannot focus only on apparently healthy waterfowl. Mortality events in seabirds and raptors can provide important warning signals. Raptors may be exposed by feeding on infected birds. Scavenging species can also help reveal where the virus is active.
In poultry, the consequences can be severe. A confirmed HPAI outbreak often leads to movement restrictions, culling of affected flocks, cleaning and disinfection, tracing, and surveillance zones. These measures are costly, but delay can allow the virus to spread further.
The H5 picture is also complicated by detections in mammals. Europe has reported infections in wild and farmed mammals in recent years, particularly in animals with exposure to infected birds or contaminated environments. Most of these events do not mean sustained mammal-to-mammal spread, but they do show why genomic monitoring matters.
The key surveillance question is no longer only “Is H5 present?” It is “Which H5 virus is present, where has it come from, and what has changed?”

H7 remains less prominent in Europe but still demands vigilance
H7 viruses receive less public attention in Europe than H5, but they remain a core surveillance target. The reason is simple: H7 viruses can also become highly pathogenic after circulation in poultry.
Europe has experience with serious H7 events. The H7N7 outbreak in the Netherlands in 2003 remains one of the clearest reminders that H7 can cause major poultry losses and human infections among exposed workers. Since then, European surveillance has continued to treat H7 detections with caution, even when viruses appear low pathogenic.
H7 detections in Europe are usually more sporadic than recent H5 activity. They may appear in wild birds or poultry and require rapid characterisation. If an H7 virus is found in poultry, laboratories assess whether it is low or highly pathogenic, including by examining the haemagglutinin cleavage site and using established diagnostic criteria.
H7 surveillance is not only about finding a large outbreak. It is also about finding small signals early.
These signals may include:
Low pathogenic H7 in domestic ducks or other poultry.
H7 detections in wild bird surveillance.
Unexplained mortality or production drops in susceptible flocks.
Genetic features that suggest adaptation during poultry circulation.
H7 also shows why surveillance must remain broad. A quiet year for one subtype does not mean the risk has disappeared. It may only mean that the right combination of host, timing, movement, and farm exposure has not occurred.
Surveillance has shifted from seasonal detection to continuous intelligence
European avian influenza surveillance has become more layered. It now combines passive surveillance, active testing, farm-level investigation, wild bird monitoring, sequencing, and cross-border data sharing.
Passive surveillance remains one of the most important tools. It depends on reporting sick or dead birds, especially wild birds found in unusual numbers or places. This approach often catches HPAI because the disease can cause visible mortality in certain species.
Active surveillance fills different gaps. It may include sampling apparently healthy wild birds, testing poultry in risk areas, checking birds before movement, or monitoring holdings linked to outbreak investigations.
The strongest systems combine both.
Surveillance route | What it helps detect | Main limitation |
Wild bird mortality reporting | HPAI activity in species that show illness or death | Misses infections in species with mild signs |
Poultry outbreak investigation | Farm-level spread and direct control needs | Often starts after clinical signs appear |
Active wild bird sampling | Low-level circulation and subtype diversity | Requires planned effort and representative sampling |
Genomic sequencing | Clades, reassortment, and links between cases | Depends on sample quality and data sharing |
Occupational health monitoring | Human exposure after infected bird contact | Requires coordination between sectors |
Europe also benefits from reference laboratory networks and shared reporting through national authorities, the European Union system, and international animal health channels. Agencies such as EFSA, ECDC, national veterinary services, and reference laboratories support risk assessment by combining field reports with laboratory results.
A major trend is the move from isolated case counting to integrated interpretation. A poultry outbreak on its own tells one story. The same outbreak, combined with wild bird detections nearby and sequence data from the virus, tells a much clearer one.
Sequencing turns outbreaks into traceable events
Molecular testing can confirm avian influenza quickly. Sequencing adds the next level of information.
Through sequencing, laboratories can identify the subtype, clade, and gene constellation of a virus. They can compare it with viruses from other countries, wild birds, previous poultry outbreaks, or mammal detections.
That comparison can reveal likely connections. It can also show when similar events are not directly connected.
For example, two farms might both report H5N1 in the same month. Without sequencing, they may look like part of one chain. With sequencing, investigators may learn that each farm was exposed to a different wild bird virus introduction. That distinction affects tracing, control priorities, and the interpretation of biosecurity gaps.
Sequencing also supports early warning when markers of concern appear. No single mutation should be overread in isolation, but patterns across the genome can signal changes that deserve closer study.
Useful genomic surveillance asks several questions:
Does the virus belong to a known clade or a new branch?
Has reassortment occurred with local low pathogenic avian influenza viruses?
Are poultry and wild bird viruses closely linked?
Are mammal detections genetically similar to nearby bird detections?
Are changes appearing repeatedly in the same host type?
The value of sequencing rises when data are shared quickly and with enough context. A sequence without location, host species, date, and outbreak setting is less useful. A well-described sequence can help neighbouring countries refine their own risk assessment.

Poultry surveillance is becoming more risk-based
Poultry surveillance in Europe increasingly targets the settings where introduction or spread is most likely. A flat, uniform testing model can miss the realities of avian influenza risk. A risk-based model pays closer attention to species, geography, season, husbandry, and contact with wild birds.
Higher-risk settings may include:
Outdoor or partially outdoor poultry systems near wetlands.
Duck and goose holdings, where infection may be harder to detect early.
Dense poultry regions with many holdings close together.
Farms near recent wild bird detections.
Holdings linked to movements, shared equipment, or service visits.
Biosecurity remains central, but surveillance helps show whether biosecurity is working. If farms with strong controls still experience introductions during intense wild bird pressure, authorities may adjust housing orders, testing intensity, or movement rules.
Vaccination has also entered the European discussion more prominently, especially for high-risk poultry sectors. France began vaccinating ducks against HPAI in 2023, which made monitoring even more important. Vaccination can reduce disease impact and viral shedding when used correctly, but it does not remove the need for surveillance. Programmes must still detect infection, track virus evolution, and distinguish infected from vaccinated birds where required.
That adds another layer to the H5 and H7 Avian Influenza in Europe picture. Control is no longer based only on stamping out and movement control. It may also include targeted vaccination, stronger farm surveillance, and genetic monitoring to check whether field viruses are changing.
Wild bird monitoring is widening beyond classic reservoir species
Wild waterbirds remain central to avian influenza ecology, but recent European experience has widened the surveillance lens. Gulls, terns, seabirds, raptors, and scavenging birds can all provide useful signals depending on the season and region.
This matters because different birds tell different parts of the story.
Ducks may carry some avian influenza viruses with few signs. Seabird die-offs may reveal intense local transmission. Raptors may point to environmental contamination or infected prey. Gulls may connect inland, coastal, and urban-adjacent environments.
Good wild bird surveillance relies on more than collecting carcasses. It needs quality species identification, location data, timing, and safe handling. It also needs public reporting channels that make it easy for people to report unusual mortality without touching sick or dead birds.
The One Health link is clear here. Wildlife health, farm biosecurity, and human exposure risk meet in the same places: wetlands, coastlines, backyard flocks, rescue centres, hunting areas, and poultry-dense regions.
Practical surveillance improves when these groups communicate:
Wildlife agencies and ornithologists.
Veterinary services and poultry producers.
Public health teams and occupational health services.
Laboratories and field responders.
Local authorities managing public spaces.
What the next phase of surveillance needs to do well
Europe’s surveillance system has become more sophisticated, but the virus continues to change. The next phase should focus on speed, coverage, and interpretation.
Three priorities stand out.
Faster connection between field events and sequence data
A dead wild bird report, a positive PCR result, and a genome sequence should not remain separate pieces of information for long. The faster they connect, the faster authorities can understand whether a detection is isolated, part of a regional pattern, or linked to a wider clade movement.
Better sampling in overlooked species and settings
Surveillance can be biased toward places where people look most often. That may leave gaps in remote coastlines, small non-commercial flocks, wildlife rehabilitation centres, or species that do not trigger obvious mortality events.
Better coverage does not always mean more random testing. It means smarter sampling guided by ecology, outbreaks, migration, and previous blind spots.
Clearer communication of uncertainty
Avian influenza risk changes with incomplete information. Authorities may need to act before every sequence is available or every pathway is confirmed. Clear communication should explain what is known, what is still being tested, and what practical action follows.
That helps avoid both panic and complacency.

The takeaway for Europe
H5 and H7 surveillance in Europe is now about much more than confirming outbreaks. It is about reading the genetic and ecological signals early enough to guide control.
For H5, recent clade 2.3.4.4b activity shows how a virus can spread widely through wild birds, enter poultry repeatedly, and create new questions through reassortment and mammal spillover. For H7, the quieter pattern should not lead to neglect. Its capacity to shift from low pathogenic to highly pathogenic in poultry keeps it firmly on the watch list.
The strongest surveillance systems connect field observation, laboratory testing, sequencing, farm investigation, and public health follow-up. They do not treat wild birds, poultry, and people as separate worlds.
The practical message is clear: Europe needs continuous, risk-based, genetically informed surveillance for H5 and H7. The virus is changing. The way it is tracked has to keep pace.




Comments